{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:28:28Z","timestamp":1782458908483,"version":"3.54.5"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:p>A case of rituximab-induced oral lichenoid drug reaction in a patient with follicular non-Hodgkin lymphoma is presented. In light of the wide use of rituximab for the treatment of lymphoma and the increasing use for autoimmune diseases, awareness and recognition of this unusual side effect of treatment with rituximab is critical to allow for prompt management to reduce morbidity.<\/jats:p>","DOI":"10.1634\/theoncologist.2014-0169","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T06:57:00Z","timestamp":1409295420000},"page":"e12-e13","source":"Crossref","is-referenced-by-count":30,"title":["Lichenoid Mucosal Reaction to Rituximab"],"prefix":"10.1093","volume":"19","author":[{"given":"Michal","family":"Kuten-Shorrer","sequence":"first","affiliation":[{"name":"Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim P.","family":"Hochberg","sequence":"additional","affiliation":[{"name":"Center for Lymphoma, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Bin","family":"Woo","sequence":"additional","affiliation":[{"name":"Dentistry, Brigham and Women's Hospital, Boston, Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"2021122308570328800_B1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cden.2004.08.004","article-title":"Lichen planus, lichenoid drug reactions, and lichenoid mucositis","volume":"49","author":"DeRossi","year":"2005","journal-title":"Dent Clin North Am"},{"issue":"suppl","key":"2021122308570328800_B2","first-page":"S25.e1","article-title":"Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations","volume":"103","author":"Al-Hashimi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2021122308570328800_B3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","article-title":"Tolerability and safety of rituximab (MabThera)","volume":"31","author":"Kimby","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"2021122308570328800_B4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/ijh.12.7","article-title":"Initial management strategies for follicular lymphoma","volume":"1","author":"Chen","year":"2012","journal-title":"Int J Hematol Oncol"},{"key":"2021122308570328800_B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13555-012-0003-9","article-title":"GA101 (a novel anti-CD20 monoclonal antibody)-induced lichenoid eruption","volume":"2","author":"Bakkour","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2021122308570328800_B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A review of the current use of rituximab in autoimmune diseases","volume":"9","author":"G\u00fcrcan","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"2021122308570328800_B7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mcna.2012.04.003","article-title":"Immunotherapies in rheumatologic disorders","volume":"96","author":"Miller","year":"2012","journal-title":"Med Clin North Am"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2014-0169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2014-0169","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/10\/e12\/41861918\/oncolo_19_10_e12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/10\/e12\/41861918\/oncolo_19_10_e12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T09:00:28Z","timestamp":1640250028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/10\/e12\/6399540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":7,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2014-0169","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10,1]]},"published":{"date-parts":[[2014,8,28]]}}}